Oxidative stress, inflammation, and cancer: How are they linked?

Durackova, 2010, Some current insights into oxidative stress, Physiol. Res., 59, 459, 10.33549/physiolres.931844

Jabs, 1999, Reactive oxygen intermediates as mediators of programmed cell death in plants and animals, Biochem. Pharmacol., 57, 231, 10.1016/S0006-2952(98)00227-5

Poyton, 2009, Mitochondrial generation of free radicals and hypoxic signaling, Trends Endocrinol. Metab., 20, 332, 10.1016/j.tem.2009.04.001

Fridovich, 1978, The biology of oxygen radicals, Science, 201, 875, 10.1126/science.210504

Goossens, 1999, Redox regulation of TNF signaling, Biofactors, 10, 145, 10.1002/biof.5520100210

Goossens, 1995, Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity, Proc. Natl Acad. Sci. USA, 92, 8115, 10.1073/pnas.92.18.8115

Hussain, 2003, Radical causes of cancer, Nat. Rev. Cancer, 3, 276, 10.1038/nrc1046

Schraufstatter, 1988, Oxidant-induced DNA damage of target cells, J. Clin. Invest., 82, 1040, 10.1172/JCI113660

Fang, 2009, Therapeutic strategies by modulating oxygen stress in cancer and inflammation, Adv. Drug Deliv. Rev., 61, 290, 10.1016/j.addr.2009.02.005

Khandrika, 2009, Oxidative stress in prostate cancer, Cancer Lett., 282, 125, 10.1016/j.canlet.2008.12.011

Visconti, 2009, New insights on oxidative stress in cancer, Curr. Opin. Drug Discov. Dev., 12, 240

Briganti, 2003, Antioxidant activity, lipid peroxidation and skin diseases: what's new, J. Eur. Acad. Dermatol. Venereol., 17, 663, 10.1046/j.1468-3083.2003.00751.x

Kinnula, 2003, Superoxide dismutases in the lung and human lung diseases, Am. J. Respir. Crit. Care Med., 167, 1600, 10.1164/rccm.200212-1479SO

Minelli, 2009, Oxidative stress-related aging: a role for prostate cancer?, Biochim. Biophys. Acta, 1795, 83

Sies, 1991, Oxidative stress: from basic research to clinical application, Am. J. Med., 91, 31S, 10.1016/0002-9343(91)90281-2

Wilson, 2001, Reactive oxygen species in acute respiratory distress syndrome, Heart Lung, 30, 370, 10.1067/mhl.2001.118298

Dugan, 2005, Reactive oxygen species and aging: evolving questions, Sci. Aging Knowl. Environ., 10.1126/sageke.2005.26.pe20

Hensley, 1996, Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide, Ann. NY Acad. Sci., 786, 120, 10.1111/j.1749-6632.1996.tb39057.x

Multhaup, 1997, Reactive oxygen species and Alzheimer's disease, Biochem. Pharmacol., 54, 533, 10.1016/S0006-2952(97)00062-2

Halliwell, 1989, Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis, Br. J. Exp. Pathol., 70, 737

Lau, 2008, Reactive oxygen species: current knowledge and applications in cancer research and therapeutic, J. Cell. Biochem., 104, 657, 10.1002/jcb.21655

Renschler, 2004, The emerging role of reactive oxygen species in cancer therapy, Eur. J. Cancer, 40, 1934, 10.1016/j.ejca.2004.02.031

Weinberg, 2009, Reactive oxygen species-dependent signaling regulates cancer, Cell. Mol. Life Sci., 66, 3663, 10.1007/s00018-009-0099-y

Touyz, 2004, Reactive oxygen species and angiotensin II signaling in vascular cells—implications in cardiovascular disease, Braz. J. Med. Biol. Res., 37, 1263, 10.1590/S0100-879X2004000800018

Yoshizumi, 2001, Signal transduction of reactive oxygen species and mitogen-activated protein kinases in cardiovascular disease, J. Med. Invest., 48, 11

Muhammad, 2009, Reactive oxygen species in diabetes-induced vascular damage, stroke, and Alzheimer's disease, J. Alzheimers Dis., 16, 775, 10.3233/JAD-2009-0982

Di Virgilio, 2004, New pathways for reactive oxygen species generation in inflammation and potential novel pharmacological targets, Curr. Pharm. Des., 10, 1647, 10.2174/1381612043384727

Moulton, 1996, Inflammatory joint disease: the role of cytokines, cyclooxygenases and reactive oxygen species, Br. J. Biomed. Sci., 53, 317

Bolanos, 2009, Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: therapeutic implications, Adv. Drug Delivery Rev., 61, 1299, 10.1016/j.addr.2009.05.009

Atabek, 2004, Oxidative stress in childhood obesity, J. Pediatr. Endocrinol. Metab., 17, 1063, 10.1515/JPEM.2004.17.8.1063

Furukawa, 2004, Increased oxidative stress in obesity and its impact on metabolic syndrome, J. Clin. Invest., 114, 1752, 10.1172/JCI21625

Tabner, 2001, Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases, Curr. Top. Med. Chem., 1, 507, 10.2174/1568026013394822

Tieu, 2003, Nitric oxide and reactive oxygen species in Parkinson's disease, IUBMB Life, 55, 329, 10.1080/1521654032000114320

Kamp, 1992, The role of free radicals in asbestos-induced diseases, Free Radic. Biol. Med., 12, 293, 10.1016/0891-5849(92)90117-Y

Kinnula, 2005, Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy, Am. J. Respir. Crit. Care Med., 172, 417, 10.1164/rccm.200501-017PP

Gelderman, 2007, Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategies, Antioxid. Redox Signaling, 9, 1541, 10.1089/ars.2007.1569

Haurani, 2007, Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: bellwether for vascular disease?, Cardiovasc. Res., 75, 679, 10.1016/j.cardiores.2007.06.016

Jeremy, 2004, Reactive oxygen species, vascular disease and cardiovascular surgery, Curr. Vasc. Pharmacol., 2, 229, 10.2174/1570161043385691

Miyajima, 1997, Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells, Br. J. Cancer, 76, 206, 10.1038/bjc.1997.363

Salganik, 2000, Dietary antioxidant depletion: enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice, Carcinogenesis, 21, 909, 10.1093/carcin/21.5.909

Brown, 2001, Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer, Breast Cancer Res., 3, 323, 10.1186/bcr315

Sharma, 2010, Oxidant/anti-oxidant dynamics in patients with advanced cervical cancer: correlation with treatment response, Mol. Cell. Biochem., 341, 65, 10.1007/s11010-010-0437-2

Oliveira, 2003, Protective effect of ascorbic acid in experimental gastric cancer: reduction of oxidative stress, World J. Gastroenterol., 9, 446, 10.3748/wjg.v9.i3.446

Calvisi, 2004, Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-alpha transgenic mouse model of liver cancer, J. Hepatol., 41, 815, 10.1016/j.jhep.2004.07.030

Azad, 2008, Inflammation and lung cancer: roles of reactive oxygen/nitrogen species, J. Toxicol. Environ. Health B Crit. Rev., 11, 1, 10.1080/10937400701436460

Fruehauf, 2008, Reactive oxygen species: an Achilles' heel of melanoma?, Expert Rev. Anticancer Ther., 8, 1751, 10.1586/14737140.8.11.1751

Kuku, 2005, Oxidant/antioxidant parameters and their relationship with medical treatment in multiple myeloma, Cell Biochem. Funct., 23, 47, 10.1002/cbf.1127

Sumi, 2010, Signal transduction pathways and transcription factors triggered by arsenic trioxide in leukemia cells, Toxicol. Appl. Pharmacol., 244, 385, 10.1016/j.taap.2010.02.012

van de Wetering, 2008, Manganese superoxide dismutase gene dosage affects chromosomal instability and tumor onset in a mouse model of T cell lymphoma, Free Radic. Biol. Med., 44, 1677, 10.1016/j.freeradbiomed.2008.01.022

Bahar, 2007, Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile, Cancer, 109, 54, 10.1002/cncr.22386

Chan, 2008, Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells, Carcinogenesis, 29, 1742, 10.1093/carcin/bgn167

Edderkaoui, 2005, Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase, Am. J. Physiol. Gastrointest. Liver Physiol., 289, G1137, 10.1152/ajpgi.00197.2005

Ma, 2009, Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma, Proc. Natl Acad. Sci. USA, 106, 8683, 10.1073/pnas.0812688106

Bartsch, 2006, Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair, Langenbecks Arch. Surg., 391, 499, 10.1007/s00423-006-0073-1

Grivennikov, 2010, Immunity, inflammation, and cancer, Cell, 140, 883, 10.1016/j.cell.2010.01.025

Grivennikov, 2010, Inflammation and oncogenesis: a vicious connection, Curr. Opin. Genet. Dev., 20, 65, 10.1016/j.gde.2009.11.004

Gonda, 2009, Chronic inflammation, the tumor microenvironment and carcinogenesis, Cell Cycle, 8, 2005, 10.4161/cc.8.13.8985

Garodia, 2007, From ancient medicine to modern medicine: Ayurvedic concepts of health and their role in inflammation and cancer, J. Soc. Integr. Oncol., 5, 25, 10.2310/7200.2006.029

Aggarwal, 2009, Inflammation and cancer: how friendly is the relationship for cancer patients?, Curr. Opin. Pharmacol., 9, 351, 10.1016/j.coph.2009.06.020

Schetter, 2010, Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways, Carcinogenesis, 31, 37, 10.1093/carcin/bgp272

Ekbom, 1990, Increased risk of large-bowel cancer in Crohn's disease with colonic involvement, Lancet, 336, 357, 10.1016/0140-6736(90)91889-I

Ekbom, 1990, Ulcerative colitis and colorectal cancer: a population-based study, N Engl J. Med., 323, 1228, 10.1056/NEJM199011013231802

Gillen, 1994, Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis, Gut, 35, 1590, 10.1136/gut.35.11.1590

Ekbom, 1993, Pancreatitis and the risk of pancreatic cancer, N Engl J. Med., 329, 1502, 10.1056/NEJM199311113292016

Coussens, 2002, Inflammation and cancer, Nature, 420, 860, 10.1038/nature01322

Kundu, 2008, Inflammation: gearing the journey to cancer, Mutat. Res., 659, 15, 10.1016/j.mrrev.2008.03.002

Aggarwal, 2009, Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe, Clin. Cancer Res., 15, 425, 10.1158/1078-0432.CCR-08-0149

Lin, 2007, A cytokine-mediated link between innate immunity, inflammation, and cancer, J. Clin. Invest., 117, 1175, 10.1172/JCI31537

Hussain, 2007, Inflammation and cancer: an ancient link with novel potentials, Int. J. Cancer, 121, 2373, 10.1002/ijc.23173

Federico, 2007, Chronic inflammation and oxidative stress in human carcinogenesis, Int. J. Cancer, 121, 2381, 10.1002/ijc.23192

Bos, 1989, ras oncogenes in human cancer: a review, Cancer Res., 49, 4682

Sparmann, 2004, Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis, Cancer Cell, 6, 447, 10.1016/j.ccr.2004.09.028

Karihtala, 2007, Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies, APMIS, 115, 81, 10.1111/j.1600-0463.2007.apm_514.x

Mates, 2000, Role of reactive oxygen species in apoptosis: implications for cancer therapy, Int. J. Biochem. Cell Biol., 32, 157, 10.1016/S1357-2725(99)00088-6

Ray, 2002, Oxidants, antioxidants and carcinogenesis, Indian J. Exp. Biol., 40, 1213

Valko, 2004, Role of oxygen radicals in DNA damage and cancer incidence, Mol. Cell. Biochem., 266, 37, 10.1023/B:MCBI.0000049134.69131.89

Marnett, 2000, Oxyradicals and DNA damage, Carcinogenesis, 21, 361, 10.1093/carcin/21.3.361

Wiseman, 1996, Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer, Biochem. J., 313, 17, 10.1042/bj3130017

Malins, 1991, Major alterations in the nucleotide structure of DNA in cancer of the female breast, Cancer Res., 51, 5430

Matsui, 2000, Increased formation of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes, Cancer Lett., 151, 87, 10.1016/S0304-3835(99)00424-3

Musarrat, 1996, Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis, Eur. J. Cancer, 32A, 1209, 10.1016/0959-8049(96)00031-7

Nathan, 1994, Regulation of biosynthesis of nitric oxide, J. Biol. Chem., 269, 13725, 10.1016/S0021-9258(17)36703-0

Davis, 2001, Novel effects of nitric oxide, Annu. Rev. Pharmacol. Toxicol., 41, 203, 10.1146/annurev.pharmtox.41.1.203

Moncada, 1993, The l-arginine–nitric oxide pathway, N Engl J. Med., 329, 2002, 10.1056/NEJM199312303292706

Lowenstein, 2004, iNOS (NOS2) at a glance, J. Cell Sci., 117, 2865, 10.1242/jcs.01166

Xie, 1994, Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase, J. Biol. Chem., 269, 4705, 10.1016/S0021-9258(17)37600-7

Zhang, 2007, The role of autophagy in mitochondria maintenance: characterization of mitochondrial functions in autophagy-deficient S. cerevisiae strains, Autophagy, 3, 337, 10.4161/auto.4127

Mathew, 2009, Autophagy suppresses tumorigenesis through elimination of p62, Cell, 137, 1062, 10.1016/j.cell.2009.03.048

Pompella, 2003, The changing faces of glutathione, a cellular protagonist, Biochem. Pharmacol., 66, 1499, 10.1016/S0006-2952(03)00504-5

Valko, 2007, Free radicals and antioxidants in normal physiological functions and human disease, Int. J. Biochem. Cell Biol., 39, 44, 10.1016/j.biocel.2006.07.001

Calvert, 1998, Clinical studies of reversal of drug resistance based on glutathione, Chem. Biol. Interact., 111–112, 213, 10.1016/S0009-2797(98)00008-8

Balendiran, 2004, The role of glutathione in cancer, Cell Biochem. Funct., 22, 343, 10.1002/cbf.1149

Estrela, 2006, Glutathione in cancer biology and therapy, Crit. Rev. Clin. Lab. Sci., 43, 143, 10.1080/10408360500523878

McCord, 1969, Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein), J. Biol. Chem., 244, 6049, 10.1016/S0021-9258(18)63504-5

Meira, 2008, DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice, J. Clin. Invest., 118, 2516

Das, 2004, DNA methylation and cancer, J. Clin. Oncol., 22, 4632, 10.1200/JCO.2004.07.151

Fleisher, 2000, Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1, Cancer Res., 60, 4864

Park, 2009, Aryl hydrocarbon receptor facilitates DNA strand breaks and 8-oxo-2′-deoxyguanosine formation by the aldo-keto reductase product benzo[a]pyrene-7, 8-dione, J. Biol. Chem., 284, 29725, 10.1074/jbc.M109.042143

Amstad, 1990, Oxidants stress induces the proto-oncogenes, C-fos and C-myc in mouse epidermal cells, Bull. Cancer, 77, 501

Amstad, 1992, Mechanism of c-fos induction by active oxygen, Cancer Res., 52, 3952

Alexander, 2010, ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS, Proc. Natl Acad. Sci. USA, 107, 4153, 10.1073/pnas.0913860107

Li, 2008, PML/RARalpha fusion protein mediates the unique sensitivity to arsenic cytotoxicity in acute promyelocytic leukemia cells: mechanisms involve the impairment of cAMP signaling and the aberrant regulation of NADPH oxidase, J. Cell. Physiol., 217, 486, 10.1002/jcp.21523

Barlow, 2008, Protein kinase A-mediated CREB phosphorylation is an oxidant-induced survival pathway in alveolar type II cells, Apoptosis, 13, 681, 10.1007/s10495-008-0203-z

Sun, 2008, Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction, J. Neurochem., 107, 265, 10.1111/j.1471-4159.2008.05616.x

Burch, 2005, Redox regulation of cell-cycle re-entry: cyclin D1 as a primary target for the mitogenic effects of reactive oxygen and nitrogen species, Antioxid. Redox Signaling, 7, 741, 10.1089/ars.2005.7.741

Franco, 2008, Oxidative stress, DNA methylation and carcinogenesis, Cancer Lett., 266, 6, 10.1016/j.canlet.2008.02.026

Maynard, 2009, Base excision repair of oxidative DNA damage and association with cancer and aging, Carcinogenesis, 30, 2, 10.1093/carcin/bgn250

Goldkorn, 2005, Life and death decisions: ceramide generation and EGF receptor trafficking are modulated by oxidative stress, Antioxid. Redox Signaling, 7, 119, 10.1089/ars.2005.7.119

Wartenberg, 2003, Reactive oxygen species-mediated regulation of eNOS and iNOS expression in multicellular prostate tumor spheroids, Int. J. Cancer, 104, 274, 10.1002/ijc.10928

McCubrey, 2006, Reactive oxygen species-induced activation of the MAP kinase signaling pathways, Antioxid. Redox Signaling, 8, 1775, 10.1089/ars.2006.8.1775

Kwon, 2001, Hydrogen peroxide triggers the expression of Fas/FasL in astrocytoma cell lines and augments apoptosis, J. Neuroimmunol., 113, 1, 10.1016/S0165-5728(00)00321-0

Goto, 2009, Transcriptional role of FOXO1 in drug resistance through antioxidant defense systems, Adv. Exp. Med. Biol., 665, 171, 10.1007/978-1-4419-1599-3_13

Kietzmann, 2005, Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression, Semin. Cell Dev. Biol., 16, 474, 10.1016/j.semcdb.2005.03.010

Ryter, 2005, Heme oxygenase-1: redox regulation of a stress protein in lung and cell culture models, Antioxid. Redox Signaling, 7, 80, 10.1089/ars.2005.7.80

Kuga, 1996, Suppression of superoxide anion production by interleukin-10 is accompanied by a downregulation of the genes for subunit proteins of NADPH oxidase, Exp. Hematol., 24, 151

Svineng, 2008, The role of reactive oxygen species in integrin and matrix metalloproteinase expression and function, Connect. Tissue Res., 49, 197, 10.1080/03008200802143166

Hellstrand, 1998, Histamine and cytokine therapy, Acta Oncol., 37, 347, 10.1080/028418698430566

Simon, 1998, Activation of the JAK–STAT pathway by reactive oxygen species, Am. J. Physiol., 275, C1640, 10.1152/ajpcell.1998.275.6.C1640

Lo, 1996, Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases, J. Biol. Chem., 271, 15703, 10.1074/jbc.271.26.15703

Skinner, 2005, Oxidative mutagenesis, mismatch repair, and aging, Sci. Aging Knowledge Environ., 10.1126/sageke.2005.9.re3

Byun, 2009, Hydrogen peroxide induces autophagic cell death in C6 glioma cells via BNIP3-mediated suppression of the mTOR pathway, Neurosci. Lett., 461, 131, 10.1016/j.neulet.2009.06.011

Venugopal, 1996, Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase 1 gene, Proc. Natl Acad. Sci. USA, 93, 14960, 10.1073/pnas.93.25.14960

Gloire, 2006, NF-kappaB activation by reactive oxygen species: fifteen years later, Biochem. Pharmacol., 72, 1493, 10.1016/j.bcp.2006.04.011

Itoh, 1997, An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements, Biochem. Biophys. Res. Commun., 236, 313, 10.1006/bbrc.1997.6943

Clerkin, 2008, Mechanisms of ROS modulated cell survival during carcinogenesis, Cancer Lett., 266, 30, 10.1016/j.canlet.2008.02.029

Torres, 2003, Redox signaling and the MAP kinase pathways, Biofactors, 17, 287, 10.1002/biof.5520170128

Han, 2008, The in vivo gene expression signature of oxidative stress, Physiol. Genomics, 34, 112, 10.1152/physiolgenomics.00239.2007

Tishler, 1993, Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents, Cancer Res., 53, 2212

Kanthasamy, 2003, Role of proteolytic activation of protein kinase Cdelta in oxidative stress-induced apoptosis, Antioxid. Redox Signaling, 5, 609, 10.1089/152308603770310275

Rusyn, 2000, Novel role of oxidants in the molecular mechanism of action of peroxisome proliferators, Antioxid. Redox Signaling, 2, 607, 10.1089/15230860050192350

Cao, 2009, Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity, EMBO J., 28, 1505, 10.1038/emboj.2009.101

Chiarugi, 2005, PTPs versus PTKs: the redox side of the coin, Free Radic. Res., 39, 353, 10.1080/10715760400027987

Ammendola, 1994, The DNA-binding efficiency of Sp1 is affected by redox changes, Eur. J. Biochem., 225, 483, 10.1111/j.1432-1033.1994.t01-1-00483.x

Ushio-Fukai, 2004, Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase, Mol. Cell. Biochem., 264, 85, 10.1023/B:MCBI.0000044378.09409.b5

Funato, 2006, The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled, Nat. Cell Biol., 8, 501, 10.1038/ncb1405

Korswagen, 2006, Regulation of the Wnt/beta-catenin pathway by redox signaling, Dev. Cell, 10, 687, 10.1016/j.devcel.2006.05.007

Droge, 2002, Free radicals in the physiological control of cell function, Physiol. Rev., 82, 47, 10.1152/physrev.00018.2001

Kerr, 1992, Signal transduction: the nuclear target, Curr. Opin. Cell Biol., 4, 496, 10.1016/0955-0674(92)90017-7

Shaulian, 2002, AP-1 as a regulator of cell life and death, Nat. Cell Biol., 4, E131, 10.1038/ncb0502-e131

Gorlach, 2007, Superoxide and derived reactive oxygen species in the regulation of hypoxia-inducible factors, Methods Enzymol., 435, 421, 10.1016/S0076-6879(07)35022-2

Liu, 2008, St Clair, D. K. ROS and p53: a versatile partnership, Free Radic. Biol. Med., 44, 1529, 10.1016/j.freeradbiomed.2008.01.011

Mantovani, 2005, Cancer: inflammation by remote control, Nature, 435, 752, 10.1038/435752a

Ames, 1992, Animal cancer tests and cancer prevention, J. Natl Cancer Inst. Monogr., 12, 125

Guyton, 1993, Oxidative mechanisms in carcinogenesis, Br. Med. Bull., 49, 523, 10.1093/oxfordjournals.bmb.a072628

Schulte-Hermann, 1990, DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion, Cancer Res., 50, 5127

Klaunig, 1998, The role of oxidative stress in chemical carcinogenesis, Environ. Health Perspect., 106, 289

Oshima, 1994, Chronic infectious and inflammation process as cancer risk factors: possible role of nitric oxide in carcinogenesis, Mutat. Res., 305, 253, 10.1016/0027-5107(94)90245-3

Rosin, 1994, Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients, Mutat. Res., 305, 283, 10.1016/0027-5107(94)90248-8

Weitzman, 1990, Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis, Blood, 76, 655, 10.1182/blood.V76.4.655.655

Frenkel, 1992, Carcinogen-mediated oxidant formation and oxidative DNA damage, Pharmacol. Ther., 53, 127, 10.1016/0163-7258(92)90047-4

Shacter, 1988, Activated neutrophils induce prolonged DNA damage in neighboring cells, Carcinogenesis, 9, 2297, 10.1093/carcin/9.12.2297

Wei, 1992, Suppression of tumor promoter-induced oxidative events and DNA damage in vivo by sarcophytol A: a possible mechanism of antipromotion, Cancer Res., 52, 2298

Hattori-Nakakuki, 1994, Formation of 8-hydroxy-2′-deoxyguanosine in epidermis of hairless mice exposed to near-UV, Biochem. Biophys. Res. Commun., 201, 1132, 10.1006/bbrc.1994.1823

Weitberg, 1989, Effect of combinations of antioxidants on phagocyte-induced sister-chromatid exchanges, Mutat. Res., 224, 1, 10.1016/0165-1218(89)90002-5

Yamashina, 1986, Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line, Cancer Res., 46, 2396

Dizdaroglu, 1993, Modification of DNA bases in chromatin of intact target human cells by activated human polymorphonuclear leukocytes, Cancer Res., 53, 1269

Trush, 1990, Comparison of oxidant activities and the activation of benzo(a)pyrene-7, 8-dihydrodiol by polymorphonuclear leucocytes from human, rat and mouse, Xenobiotica, 20, 925, 10.3109/00498259009046908

Trush, 1991, An overview of the relationship between oxidative stress and chemical carcinogenesis, Free Radic. Biol. Med., 10, 201, 10.1016/0891-5849(91)90077-G

Jackson, 2001, The contribution of endogenous sources of DNA damage to the multiple mutations in cancer, Mutat. Res., 477, 7, 10.1016/S0027-5107(01)00091-4

Storz, 2005, Reactive oxygen species in tumor progression, Front. Biosci., 10, 1881, 10.2741/1667

Kroncke, 2003, Nitrosative stress and transcription, Biol. Chem., 384, 1365, 10.1515/BC.2003.153

Cerutti, 1991, Inflammation and oxidative stress in carcinogenesis, Cancer Cells, 3, 1

Cerutti, 1985, Prooxidant states and tumor promotion, Science, 227, 375, 10.1126/science.2981433

Slaga, 1981, Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound, Science, 213, 1023, 10.1126/science.6791284

Kamata, 2009, Roles of Nox1 and other Nox isoforms in cancer development, Cancer Sci., 100, 1382, 10.1111/j.1349-7006.2009.01207.x

Los, 2009, Switching Akt: from survival signaling to deadly response, Bioessays, 31, 492, 10.1002/bies.200900005

Azad, 2009, Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment, Antioxid. Redox Signaling, 11, 777, 10.1089/ars.2008.2270

Manning, 2007, AKT/PKB signaling: navigating downstream, Cell, 129, 1261, 10.1016/j.cell.2007.06.009

Plas, 2005, Akt-dependent transformation: there is more to growth than just surviving, Oncogene, 24, 7435, 10.1038/sj.onc.1209097

Muller, 1997, Antioxidants as well as oxidants activate c-fos via Ras-dependent activation of extracellular-signal-regulated kinase 2 and Elk-1, Eur. J. Biochem., 244, 45, 10.1111/j.1432-1033.1997.00045.x

Pennington, 2005, Redox-sensitive signaling factors as novel molecular targets for cancer therapy, Drug Resist. Update, 8, 322, 10.1016/j.drup.2005.09.002

Xia, 1995, Opposing effects of ERK and JNK–p38 MAP kinases on apoptosis, Science, 270, 1326, 10.1126/science.270.5240.1326

Chang, 2001, Mammalian MAP kinase signalling cascades, Nature, 410, 37, 10.1038/35065000

Gupta, 1995, Transcription factor ATF2 regulation by the JNK signal transduction pathway, Science, 267, 389, 10.1126/science.7824938

Karin, 1995, The regulation of AP-1 activity by mitogen-activated protein kinases, J. Biol. Chem., 270, 16483, 10.1074/jbc.270.28.16483

Baldwin, 1996, The NF-kappa B and I kappa B proteins: new discoveries and insights, Annu. Rev. Immunol., 14, 649, 10.1146/annurev.immunol.14.1.649

Baeuerle, 1988, Phorbol-ester-induced activation of the NF-kappa B transcription factor involves dissociation of an apparently cytoplasmic NF-kappa B/inhibitor complex, Cold Spring Harb. Symp. Quant. Biol., 53, 789, 10.1101/SQB.1988.053.01.089

Li, 1998, Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms, Proc. Natl Acad. Sci. USA, 95, 13012, 10.1073/pnas.95.22.13012

Rath, 2001, Antiproliferative effects of IFN-alpha correlate with the downregulation of nuclear factor-kappa B in human Burkitt lymphoma Daudi cells, J. Interferon Cytokine Res., 21, 523, 10.1089/10799900152434402

Bours, 1994, The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines, Biochem. Pharmacol., 47, 145, 10.1016/0006-2952(94)90448-0

Delhalle, 2002, NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis, Oncogene, 21, 3917, 10.1038/sj.onc.1205489

Pham, 2004, Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species, Cell, 119, 529, 10.1016/j.cell.2004.10.017

Schulze-Osthoff, 1998, Apoptosis signaling by death receptors, Eur. J. Biochem., 254, 439, 10.1046/j.1432-1327.1998.2540439.x

Giri, 1998, Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells: autocrine role of tumor necrosis factor and reactive oxygen intermediates, J. Biol. Chem., 273, 14008, 10.1074/jbc.273.22.14008

Nomura, 2000, Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (−)-epigallocatechin gallate and theaflavins, Carcinogenesis, 21, 1885, 10.1093/carcin/21.10.1885

Schulze-Osthoff, 1997, Oxidative stress and signal transduction, Int. J. Vitam. Nutr. Res., 67, 336

Sun, 1990, Free radicals, antioxidant enzymes, and carcinogenesis, Free Radic. Biol. Med., 8, 583, 10.1016/0891-5849(90)90156-D

Schmidt, 1995, The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B, Chem. Biol., 2, 13, 10.1016/1074-5521(95)90076-4

Kass, 1989, Activation of hepatocyte protein kinase C by redox-cycling quinones, Biochem. J., 260, 499, 10.1042/bj2600499

Larsson, 1989, Translocation and enhancement of phosphotransferase activity of protein kinase C following exposure in mouse epidermal cells to oxidants, Cancer Res., 49, 5627

Konishi, 1997, Activation of protein kinase B (Akt/RAC-protein kinase) by cellular stress and its association with heat shock protein Hsp27, FEBS Lett., 410, 493, 10.1016/S0014-5793(97)00541-3

D'Souza, 1993, Interactions of hydrogen peroxide with interleukin-6 and platelet-derived growth factor in determining mesangial cell growth: effect of repeated oxidant stress, Clin. Sci. (London), 85, 747, 10.1042/cs0850747

Alliangana, 1996, Effects of beta-carotene, flavonoid quercitin and quinacrine on cell proliferation and lipid peroxidation breakdown products in BHK-21 cells, East Afr. Med. J., 73, 752

Chang, 2007, Induction of necrosis and apoptosis to KB cancer cells by sanguinarine is associated with reactive oxygen species production and mitochondrial membrane depolarization, Toxicol. Appl. Pharmacol., 218, 143, 10.1016/j.taap.2006.10.025

Dypbukt, 1994, Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F cells: the role of intracellular polyamines, J. Biol. Chem., 269, 30553, 10.1016/S0021-9258(18)43849-5

Halliwell, 2007, Oxidative stress and cancer: have we moved forward?, Biochem. J., 401, 1, 10.1042/BJ20061131

Kundu, 1995, Sublethal oxidative stress inhibits tumor cell adhesion and enhances experimental metastasis of murine mammary carcinoma, Clin. Exp. Metastasis, 13, 16, 10.1007/BF00144014

Roebuck, 1999, Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB, Int. J. Mol. Med., 4, 223

Westermarck, 1999, Regulation of matrix metalloproteinase expression in tumor invasion, FASEB J., 13, 781, 10.1096/fasebj.13.8.781

Mori, 2004, Invasive potential induced under long-term oxidative stress in mammary epithelial cells, Cancer Res., 64, 7464, 10.1158/0008-5472.CAN-04-1725

Nelson, 2000, Matrix metalloproteinases: biologic activity and clinical implications, J. Clin. Oncol., 18, 1135, 10.1200/JCO.2000.18.5.1135

Rajagopalan, 1996, Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: implications for atherosclerotic plaque stability, J. Clin. Invest., 98, 2572, 10.1172/JCI119076

Nelson, 2004, Mitochondrial redox control of matrix metalloproteinases, Free Radic. Biol. Med., 37, 768, 10.1016/j.freeradbiomed.2004.06.008

Yoon, 2002, Sustained production of H2O2 activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-kappa B pathway, J. Biol. Chem., 277, 30271, 10.1074/jbc.M202647200

Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9

Kollmar, 2007, Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis, Neoplasia, 9, 862, 10.1593/neo.07559

Owen, 1997, Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins, Int. J. Cancer, 73, 94, 10.1002/(SICI)1097-0215(19970926)73:1<94::AID-IJC15>3.0.CO;2-5

Yuecheng, 2007, Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2, Eur. J. Cancer Prev., 16, 430, 10.1097/01.cej.0000236259.88146.a4

Lu, 2006, Inflammation, a key event in cancer development, Mol. Cancer Res., 4, 221, 10.1158/1541-7786.MCR-05-0261

Wen, 2008, Silencing of CXCR4 inhibits the proliferation, adhesion, chemotaxis and invasion of salivary gland mucoepidermoid carcinoma Mc3 cells in vitro, Oral Oncol., 44, 545, 10.1016/j.oraloncology.2007.06.016

van Wetering, 2002, Reactive oxygen species mediate Rac-induced loss of cell–cell adhesion in primary human endothelial cells, J. Cell Sci., 115, 1837, 10.1242/jcs.115.9.1837

Diers, 2010, Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy, Biochem. J., 430, 69, 10.1042/BJ20091193

Stamatakis, 2006, Prostanoids with cyclopentenone structure as tools for the characterization of electrophilic lipid–protein interactomes, Ann. NY Acad. Sci., 1091, 548, 10.1196/annals.1378.096

Stamatakis, 2006, Identification of novel protein targets for modification by 15-deoxy-Delta12, 14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton, J. Am. Soc. Nephrol., 17, 89, 10.1681/ASN.2005030329

Aldini, 2007, Identification of actin as a 15-deoxy-Delta12, 14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational, and functional approaches to investigate the effect on cytoskeletal derangement, Biochemistry, 46, 2707, 10.1021/bi0618565

Cheng, 2004, Oxidative stress and thioredoxin-interacting protein promote intravasation of melanoma cells, Exp. Cell Res., 300, 297, 10.1016/j.yexcr.2004.07.014

Folkman, 1985, Tumor angiogenesis, Adv. Cancer Res., 43, 175, 10.1016/S0065-230X(08)60946-X

Aruoma, 1987, Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals from hydrogen peroxide in the presence of iron: are lactoferrin and transferrin promoters of hydroxyl-radical generation?, Biochem. J., 241, 273, 10.1042/bj2410273

Liotta, 1991, Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation, Cell, 64, 327, 10.1016/0092-8674(91)90642-C

North, 2005, Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors, Cancer Lett., 218, 1, 10.1016/j.canlet.2004.08.007

Bergers, 2003, Tumorigenesis and the angiogenic switch, Nat. Rev. Cancer, 3, 401, 10.1038/nrc1093

Chandel, 1998, Mitochondrial reactive oxygen species trigger hypoxia-induced transcription, Proc. Natl Acad. Sci. USA, 95, 11715, 10.1073/pnas.95.20.11715

Mazure, 1996, Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression, Cancer Res., 56, 3436

Okada, 1998, Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells, Proc. Natl Acad. Sci. USA, 95, 3609, 10.1073/pnas.95.7.3609

Van Meir, 1994, Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells, Nat. Genet., 8, 171, 10.1038/ng1094-171

Longo, 2002, Anti-angiogenic therapy: rationale, challenges and clinical studies, Angiogenesis, 5, 237, 10.1023/A:1024532022166

Alon, 1995, Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity, Nat. Med., 1, 1024, 10.1038/nm1095-1024

Eatock, 2000, Tumour vasculature as a target for anticancer therapy, Cancer Treat. Rev., 26, 191, 10.1053/ctrv.1999.0158

Monte, 1997, Hydrogen peroxide is involved in lymphocyte activation mechanisms to induce angiogenesis, Eur. J. Cancer, 33, 676, 10.1016/S0959-8049(96)00506-0

Monte, 1994, Inhibition of lymphocyte-induced angiogenesis by free radical scavengers, Free Radic. Biol. Med., 17, 259, 10.1016/0891-5849(94)90081-7

Harris, 2002, Hypoxia—a key regulatory factor in tumour growth, Nat. Rev. Cancer, 2, 38, 10.1038/nrc704

Hockel, 1999, Hypoxic cervical cancers with low apoptotic index are highly aggressive, Cancer Res., 59, 4525

Hockel, 2001, Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects, J. Natl Cancer Inst., 93, 266, 10.1093/jnci/93.4.266

Roessner, 2008, Oxidative stress in ulcerative colitis-associated carcinogenesis, Pathol. Res. Pract., 204, 511, 10.1016/j.prp.2008.04.011

Martey, 2004, Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer, Am. J. Physiol. Lung Cell. Mol. Physiol., 287, L981, 10.1152/ajplung.00239.2003

Garcea, 2005, Role of inflammation in pancreatic carcinogenesis and the implications for future therapy, Pancreatology, 5, 514, 10.1159/000087493

Murphy, 2005, Have patients with esophagitis got an increased risk of adenocarcinoma? Results from a population-based study, World J. Gastroenterol., 11, 7290, 10.3748/wjg.v11.i46.7290

de Visser, 2009, Towards understanding the role of cancer-associated inflammation in chemoresistance, Curr. Pharm. Des., 15, 1844, 10.2174/138161209788453239

Borst, 2007, What makes tumors multidrug resistant?, Cell Cycle, 6, 2782, 10.4161/cc.6.22.4936

Schmitt, 2002, A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy, Cell, 109, 335, 10.1016/S0092-8674(02)00734-1

Szakacs, 2006, Targeting multidrug resistance in cancer, Nat. Rev. Drug Discov., 5, 219, 10.1038/nrd1984

Voorzanger-Rousselot, 2006, CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways, BMC Cancer, 6, 75, 10.1186/1471-2407-6-75

Ho, 2006, Regulation of multidrug resistance by pro-inflammatory cytokines, Curr. Cancer Drug Targets, 6, 295, 10.2174/156800906777441753

Petrovic, 2007, Regulation of drug transporters during infection and inflammation, Mol. Interv., 7, 99, 10.1124/mi.7.2.10

Hartmann, 2005, Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice, Drug Metab. Dispos., 33, 820, 10.1124/dmd.104.002568

Blokzijl, 2008, Up-regulation and cytoprotective role of epithelial multidrug resistance-associated protein 1 in inflammatory bowel disease, J. Biol. Chem., 283, 35630, 10.1074/jbc.M804374200

Bottero, 2001, Activation of nuclear factor kappaB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: a brake to apoptosis in HeLa human carcinoma cells, Cancer Res., 61, 7785

Das, 1997, Activation of NF-kappaB by antineoplastic agents: role of protein kinase C, J. Biol. Chem., 272, 14914, 10.1074/jbc.272.23.14914

Piret, 1996, Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells, Nucleic Acids Res., 24, 4242, 10.1093/nar/24.21.4242

Ahn, 2007, Nuclear factor-kappa B: from clone to clinic, Curr. Mol. Med., 7, 619, 10.2174/156652407782564363

Raju, 1998, IkappaBalpha degradation is not a requirement for the X-ray-induced activation of nuclear factor kappaB in normal rat astrocytes and human brain tumour cells, Int. J. Radiat. Biol., 74, 617, 10.1080/095530098141195

Chen, 2008, Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells, Oncogene, 27, 4712, 10.1038/onc.2008.112

Kelly, 2006, TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer, Cancer Res., 66, 3859, 10.1158/0008-5472.CAN-05-3948

Braunstein, 2008, Acquisition of stable inducible up-regulation of nuclear factor-kappaB by tumor necrosis factor exposure confers increased radiation resistance without increased transformation in breast cancer cells, Mol. Cancer Res., 6, 78, 10.1158/1541-7786.MCR-07-0339

Douglas, 1987, Mechanism of action of glutathione-dependent enzymes, Adv. Enzymol. Relat. Areas Mol. Biol., 59, 103

Sau, 2010, Glutathione transferases and development of new principles to overcome drug resistance, Arch. Biochem. Biophys., 500, 116, 10.1016/j.abb.2010.05.012

Hayes, 2005, Glutathione transferases, Annu. Rev. Pharmacol. Toxicol., 45, 51, 10.1146/annurev.pharmtox.45.120403.095857

Lau, 2008, Dual roles of Nrf2 in cancer, Pharmacol. Res., 58, 262, 10.1016/j.phrs.2008.09.003

Wang, 2008, Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2, Carcinogenesis, 29, 1235, 10.1093/carcin/bgn095

Cho, 2008, Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance, Cancer Lett., 260, 96, 10.1016/j.canlet.2007.10.022

Padmanabhan, 2006, Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer, Mol. Cell, 21, 689, 10.1016/j.molcel.2006.01.013

Singh, 2006, Dysfunctional KEAP1–NRF2 interaction in non-small-cell lung cancer, PLoS Med., 3, e420, 10.1371/journal.pmed.0030420

Jozkowicz, 2007, Heme oxygenase-1 in tumors: is it a false friend?, Antioxid. Redox Signaling, 9, 2099, 10.1089/ars.2007.1659

Brigelius-Flohe, 2008, Selenium compounds and selenoproteins in cancer, Chem. Biodivers., 5, 389, 10.1002/cbdv.200890039

Kim, 2007, Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer, Clin. Cancer Res., 13, 3875, 10.1158/1078-0432.CCR-06-2893

Kim, 2007, Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology, Cancer Res., 67, 546, 10.1158/0008-5472.CAN-06-2401

Persons, 1999, Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin, Clin. Cancer Res., 5, 1007

Steinmetz, 2004, Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation, Mol. Endocrinol., 18, 2570, 10.1210/me.2004-0082

Camps, 2000, Dual specificity phosphatases: a gene family for control of MAP kinase function, FASEB J., 14, 6, 10.1096/fasebj.14.1.6

Keyse, 2000, Protein phosphatases and the regulation of mitogen-activated protein kinase signalling, Curr. Opin. Cell Biol., 12, 186, 10.1016/S0955-0674(99)00075-7

Nichols, 2000, Substrate recognition domains within extracellular signal-regulated kinase mediate binding and catalytic activation of mitogen-activated protein kinase phosphatase-3, J. Biol. Chem., 275, 24613, 10.1074/jbc.M001515200

Kim, 2005, Repopulation of cancer cells during therapy: an important cause of treatment failure, Nat. Rev. Cancer, 5, 516, 10.1038/nrc1650

Olivieri, 1984, Adaptive response of human lymphocytes to low concentrations of radioactive thymidine, Science, 223, 594, 10.1126/science.6695170

Orlowski, 2002, NF-kappaB as a therapeutic target in cancer, Trends Mol. Med., 8, 385, 10.1016/S1471-4914(02)02375-4

Fan, 2007, Nuclear factor-kappaB and manganese superoxide dismutase mediate adaptive radioresistance in low-dose irradiated mouse skin epithelial cells, Cancer Res., 67, 3220, 10.1158/0008-5472.CAN-06-2728

Guo, 2003, Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses, Mol. Cell. Biol., 23, 2362, 10.1128/MCB.23.7.2362-2378.2003

Li, 2001, Effector genes altered in MCF-7 human breast cancer cells after exposure to fractionated ionizing radiation, Radiat. Res., 155, 543, 10.1667/0033-7587(2001)155[0543:EGAIMH]2.0.CO;2

Izzo, 2006, Association of activated transcription factor nuclear factor kappaB with chemoradiation resistance and poor outcome in esophageal carcinoma, J. Clin. Oncol., 24, 748, 10.1200/JCO.2005.03.8810

Sandur, 2009, Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity, Int. J. Radiat. Oncol. Biol. Phys., 75, 534, 10.1016/j.ijrobp.2009.06.034

De Ridder, 2008, Hypoxic tumor cell radiosensitization through nitric oxide, Nitric Oxide, 19, 164, 10.1016/j.niox.2008.04.015

Janssens, 1999, Radiosensitization of hypoxic tumour cells by S-nitroso-N-acetylpenicillamine implicates a bioreductive mechanism of nitric oxide generation, Br. J. Cancer, 79, 1085, 10.1038/sj.bjc.6690173

Kimura, 1999, Tumor necrosis factor-alpha sensitizes prostate cancer cells to gamma-irradiation-induced apoptosis, Cancer Res., 59, 1606

Mitchell, 1993, Hypoxic mammalian cell radiosensitization by nitric oxide, Cancer Res., 53, 5845

Sersa, 1988, Anti-tumor effects of tumor necrosis factor alone or combined with radiotherapy, Int. J. Cancer, 42, 129, 10.1002/ijc.2910420124

Verovski, 1996, Intrinsic radiosensitivity of human pancreatic tumour cells and the radiosensitising potency of the nitric oxide donor sodium nitroprusside, Br. J. Cancer, 74, 1734, 10.1038/bjc.1996.623

Bonnet, 1997, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat. Med., 3, 730, 10.1038/nm0797-730

Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc. Natl Acad. Sci. USA, 100, 3983, 10.1073/pnas.0530291100

Collins, 2005, Prospective identification of tumorigenic prostate cancer stem cells, Cancer Res., 65, 10946, 10.1158/0008-5472.CAN-05-2018

Li, 2007, Identification of pancreatic cancer stem cells, Cancer Res., 67, 1030, 10.1158/0008-5472.CAN-06-2030

Ricci-Vitiani, 2007, Identification and expansion of human colon-cancer-initiating cells, Nature, 445, 111, 10.1038/nature05384

Schatton, 2008, Identification of cells initiating human melanomas, Nature, 451, 345, 10.1038/nature06489

Singh, 2004, Identification of human brain tumour initiating cells, Nature, 432, 396, 10.1038/nature03128

Szotek, 2006, Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness, Proc. Natl Acad. Sci. USA, 103, 11154, 10.1073/pnas.0603672103

Korkaya, 2007, Selective targeting of cancer stem cells: a new concept in cancer therapeutics, BioDrugs, 21, 299, 10.2165/00063030-200721050-00002

Diehn, 2009, Association of reactive oxygen species levels and radioresistance in cancer stem cells, Nature, 458, 780, 10.1038/nature07733

Baba, 2009, Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells, Oncogene, 28, 209, 10.1038/onc.2008.374

Ma, 2008, CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway, Oncogene, 27, 1749, 10.1038/sj.onc.1210811

Rhee, 2001, Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel, In Vitro Cell. Dev. Biol. Anim., 37, 127, 10.1290/1071-2690(2001)037<0127:PPAGCO>2.0.CO;2

Thalmann, 1994, Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer, Cancer Res., 54, 2577

Josson, 2010, Tumor–stroma co-evolution in prostate cancer progression and metastasis, Semin. Cell Dev. Biol., 21, 26, 10.1016/j.semcdb.2009.11.016

De Marzo, 2007, Inflammation, atrophy, and prostate carcinogenesis, Urol. Oncol., 25, 398, 10.1016/j.urolonc.2007.05.007

Sung, 2008, Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis, Cancer Res., 68, 9996, 10.1158/0008-5472.CAN-08-2492

Chung, 2005, Molecular insights into prostate cancer progression: the missing link of tumor microenvironment, J. Urol., 173, 10, 10.1097/01.ju.0000141582.15218.10

Porta, 2009, Cellular and molecular pathways linking inflammation and cancer, Immunobiology, 214, 761, 10.1016/j.imbio.2009.06.014

Mantovani, 2009, Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation, Hum. Immunol., 70, 325, 10.1016/j.humimm.2009.02.008

Sica, 2007, Altered macrophage differentiation and immune dysfunction in tumor development, J. Clin. Invest., 117, 1155, 10.1172/JCI31422

Balkwill, 2005, Smoldering and polarized inflammation in the initiation and promotion of malignant disease, Cancer Cell, 7, 211, 10.1016/j.ccr.2005.02.013

Balkwill, 2001, Inflammation and cancer: back to Virchow?, Lancet, 357, 539, 10.1016/S0140-6736(00)04046-0

Mantovani, 2008, Cancer-related inflammation, Nature, 454, 436, 10.1038/nature07205

Mantovani, 2002, Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes, Trends Immunol., 23, 549, 10.1016/S1471-4906(02)02302-5

Hiratsuka, 2002, MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis, Cancer Cell, 2, 289, 10.1016/S1535-6108(02)00153-8

Surh, 2005, Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals, J. Nutr., 135, 2993S, 10.1093/jn/135.12.2993S

Virgili, 2008, Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity, Free Radic. Biol. Med., 45, 1205, 10.1016/j.freeradbiomed.2008.08.001